Source:http://linkedlifedata.com/resource/pubmed/id/16690340
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-6-20
|
pubmed:abstractText |
Genomics is accelerating the progress in data generation and interpretation in the global analyses of components of cells, including the spectrum of lipids, RNA, metabolites, proteins, mutational phenotypes or DNA methylation sites. Integration of the knowledge generated by these diverse strategies is predicted to have a tremendous impact on approaches to rational drug discovery against infectious diseases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1286-4579
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1654-61
|
pubmed:meshHeading |
pubmed-meshheading:16690340-Anti-Infective Agents,
pubmed-meshheading:16690340-Communicable Diseases,
pubmed-meshheading:16690340-Drug Design,
pubmed-meshheading:16690340-Genomics,
pubmed-meshheading:16690340-Humans,
pubmed-meshheading:16690340-Pharmacogenetics,
pubmed-meshheading:16690340-Systems Biology
|
pubmed:year |
2006
|
pubmed:articleTitle |
The impact of genomics on discovering drugs against infectious diseases.
|
pubmed:affiliation |
National Institutes of Health, Tuberculosis Research Section, LIG/NIAID/NIH, Twinbrook II, Room 239, 12441 Parklawn Drive, Rockville, MD 20852, USA. hboshoff@niaid.nih.gov
|
pubmed:publicationType |
Journal Article,
Review
|